Page last updated: 2024-10-19

niacinamide and Colonic Diseases

niacinamide has been researched along with Colonic Diseases in 3 studies

nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.

Colonic Diseases: Pathological processes in the COLON region of the large intestine (INTESTINE, LARGE).

Research Excerpts

ExcerptRelevanceReference
"A 66-year-old man with malignant melanoma was treated with sorafenib, 2 yen 400 mg per day."7.75Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib. ( Frieling, T; Heise, J; Wassilew, SW, 2009)
"A 66-year-old man with malignant melanoma was treated with sorafenib, 2 yen 400 mg per day."3.75Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib. ( Frieling, T; Heise, J; Wassilew, SW, 2009)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Frieling, T1
Heise, J1
Wassilew, SW1
FELIX, H1
Eng, FC1
Easson, AM1
Szentgyorgyi, E1
Knox, JJ1

Other Studies

3 other studies available for niacinamide and Colonic Diseases

ArticleYear
Multiple colon ulcerations, perforation and death during treatment of malignant melanoma with sorafenib.
    Deutsche medizinische Wochenschrift (1946), 2009, Volume: 134, Issue:28-29

    Topics: Abdomen, Acute; Aged; Antineoplastic Agents; Benzenesulfonates; Colectomy; Colonic Diseases; Diarrhe

2009
[Deficiency in vitamin PP and colopathies].
    La Semaine des hopitaux: therapeutique, 1962, Volume: 38

    Topics: Colon; Colonic Diseases; Disease; Gastrointestinal Diseases; Niacin; Niacinamide; Pellagra

1962
Sorafenib and surgical complications: a case report of adverse reaction to sorafenib during treatment for renal cell carcinoma.
    European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology, 2009, Volume: 35, Issue:2

    Topics: Adult; Antineoplastic Agents; Benzenesulfonates; Carcinoma, Renal Cell; Colonic Diseases; Colonoscop

2009